GH1 and isolated congenital growth hormone deficiency: compared studies between GHD and ISS patients on GH therapy of which one study reported a height gain of 1.3 SDS over an average of 4.6 years in patients with IGHD while another study reported a gain of only 0.5 SD in patients with ISS over an average of 4.4 years (24).